Meridian Bioscience (VIVO) Reports Q4 EPS of $0.19, Offers FY21 Guidance

Go back to Meridian Bioscience (VIVO) Reports Q4 EPS of $0.19, Offers FY21 Guidance
Meridian Bioscience, Inc. (NASDAQ: VIVO) Delayed: 5.39 -0.21 (3.75%)
Previous Close $5.60    52 Week High $21.49 
Open $5.61    52 Week Low $15.75 
Day High $5.68    P/E 6.13 
Day Low $5.25    EPS $0.88 
Volume 333,202